ODMA Member, Hoya Lenses has announced a roll out of “D.I.M.S. Technology”. Clinical research shows children wearing the lenses have significantly less myopia progression as compared with those wearing the single-vision lenses.
HOYA Corporation, a key player in the global market for ophthalmic lenses, is proud to announce a new product launch in the Asian Summer 2018: MyoSmart with D.I.M.S. Technology, a lens for myopia control in children and youth, developed in cooperation with their partner, The Hong Kong Polytechnic University. Wearing defocus spectacles daily significantly slows myopia progression and axial elongation in myopic school children aged 8 to 13, according to a two-year double-blind randomised clinical trial in which 160 Chinese myopic children in Hong
Following the trial, which began in 2014, children wearing defocus lenses had 60 per cent less myopia progression and in 21.5 per cent of the children, the myopia progression halted completely. The findings provide strong evidence that defocus lenses are effective in reducing myopia progression. In 2012, HOYA Corporation and The Hong Kong Polytechnic University launched a cooperation with the focus on developing a new myopia control lens which is capable of preventing myopia from worsening or slowing down its progression.
Following years of academic studies, product design and clinical research, HOYA Corporation and The Hong Kong Polytechnic University developed a revolutionary spectacle lens, based
on a Defocus Incorporated Multiple Segments Technology or “D.I.M.S. Technology”, which just successfully won the Grand Prize, Grand Award and Gold Medal at the 46th International
Exhibition of Inventions of Geneva in April 2018.
The lens, which has a smooth surface and looks almost identical to a regular lens was presented on the 6 March at a symposium in Shanghai which was organized by Hoya. A second successful symposium for key opinion leaders, “Symposium of Defocus Theory and Clinical Results in Myopia Control”, was held at Hong Kong Hyatt Regency Hotel on 25 April,
organized by Hoya Lens HK Ltd. and the Global Marketing team. Both events were attended by over 30 key opinion leaders and the D.I.M.S. Technology was very well received.
MyoSmart lenses will be launched in Hong Kong and China in the summer of 2018. A broader, global launch is slated to begin in 2019/2020. At this stage, we do not have a launch date for Australia and New Zealand.
Founded in 1941 in Tokyo, Japan, Hoya is a global technology and med-tech company, and a leading supplier of innovative high-tech and medical products. Hoya is active in the fields of
healthcare and information technology, providing eyeglasses, medical endoscopes, intraocular lenses, optical lenses, as well as key components for semiconductor devices, LCD panels and HDDs. With over 150 offices and subsidiaries worldwide, Hoya currently employs a multinational workforce of over 34,000 people. For more information, please visit http://www.hoya.com
About HOYA Vision Care
For over 60 years, HOYA Vision Care has been a global leader in the eyeglass lens business. With a presence in over 50 countries, Hoya Vision Care has a proven expertise in lens designs
and freeform surfacing technology combined with a leading position in high performance, quality AR coating. HOYA Vision Care’s solid market portfolio includes SEIKO and PENTAX
optical lenses, as well as innovative products such as Hoyalux iD MyStyle V+ progressive lenses and Yuniku, vision-centric 3D tailored eyewear. The company employs over 16,000
employees worldwide with mass production facilities in Asia & Europe and over 40 local Rx laboratories globally.